Delivery Order SPE2DB20D3505-SPE2DB25FU4K7
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FG5C0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,736.59 firm fixed-price delivery order is for the supply of 4,565,229,840 units of the medication Vyvanse 20 mg capsules. The contract has a period of performance through July 24, 2024 and was awarded on July 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB24D1104|SPE2DB25FXZY4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,371.01 firm-fixed-price delivery order is for the supply of 4,567,937,942 units of the 70 mg capsule formulation of the medication Vyvanse. The contract has an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award with ID SPE2DX22D0010|SPE2D825FAM02 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,265.36 firm-fixed-price delivery order is for the supply of 4566118280 - Vyvanse Capsules 30mg. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,307.32, is a delivery order for the supply of Vyvanse 20 mg capsules. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,524.90 firm fixed-price delivery order is for the supply of 4,564,337,332 units of Vyvanse 20 mg capsules. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $1,160.95 Firm Fixed Price Delivery Order, is for the supply of 4,567,956,581 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of April 17, 2025 and was awarded on April 16, 2025. The award is not designated as a set-aside contract, indicating open...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY3QY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,536.64 firm fixed-price delivery order is for the supply of 4,568,000 units of the 40mg capsule formulation of the medication Vyvanse. The contract has an ultimate completion date of April 23, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, identified as SPE2DB22D3016|SPE2DB25FATP8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,407.62 delivery order is for the supply of 4,567,875,642 units of Vyvanse 20 mg chewable tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,868.93 firm fixed-price delivery order is for the supply of 4,565,639,987 Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...